SteelPeak Wealth LLC Increases Stake in Cigna Group $CI

SteelPeak Wealth LLC increased its stake in Cigna Group (NYSE:CI) by 614.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,068 shares of the health services provider’s stock after purchasing an additional 5,219 shares during the period. SteelPeak Wealth LLC’s holdings in Cigna Group were worth $1,670,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CI. Harbor Capital Advisors Inc. increased its stake in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares in the last quarter. Beacon Financial Strategies CORP acquired a new stake in shares of Cigna Group during the fourth quarter worth $28,000. Lodestone Wealth Management LLC purchased a new stake in shares of Cigna Group during the fourth quarter valued at $32,000. Collier Financial purchased a new stake in shares of Cigna Group during the third quarter valued at $34,000. Finally, True Wealth Design LLC increased its position in shares of Cigna Group by 116.4% in the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after acquiring an additional 85 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of research reports. TD Cowen lifted their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Royal Bank Of Canada cut their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. Jefferies Financial Group raised their price objective on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Robert W. Baird decreased their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. Finally, Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $307.00 to $358.00 in a report on Thursday, March 12th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

NYSE:CI opened at $270.30 on Friday. The firm’s fifty day moving average is $276.19 and its two-hundred day moving average is $279.13. The firm has a market cap of $71.23 billion, a price-to-earnings ratio of 12.19, a PEG ratio of 0.94 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter last year, the business posted $6.64 EPS. The company’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date of this dividend was Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.